We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
Industry Insight

A team of multidisciplinary scientists – including bioengineers, materials-scientists and immunologists – at the Wyss Institute has created a novel infection vaccine platform know as OmniVax. Technology Networks spoke with Lead Senior Staff Scientist Ed Doherty from the Wyss Institute for Biologically Inspired Engineering at Harvard University, to learn more.

Read More

Targeting “Undruggable” Proteins by Selectively Controlling mRNA Translation
Industry Insight

Up to 80% of proteins do not possess binding sites suitable for direct binding of small molecule drugs, making them “undruggable”. To overcome this problem, Anima Biotech has developed a platform to identify drugs with the ability to interfere with the production of these “undruggable” proteins, by selectively inhibiting the translation of mRNA.

Read More

Scripps Research Spin-Off Ushers a "New Era" in Vaccinology With Platform Technology
Industry Insight

Scripps Research spin-off company Ufovax employs the single-component self-assembling protein nanoparticle (1c-SApNP®) platform technology, that was created in the laboratory of Professor Jiang Zhu, to address some of the key challenges in modern vaccine development. We spoke with Dr Colette Saccomanno to learn more.

Read More

Towards a Deeper Understanding of the Proteomic Landscape
Industry Insight

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.

Read More

Progress in Stem Cell Therapy for Transplant, Stroke and ARDS Patients
Industry Insight

Technology Networks spoke with Gil Van Bokkelen, CEO of Athersys, to learn more about MultiStem and the main mechanisms of action the cells have on the body. Gil also discussed some of the additional indications that the cells are being investigated as potential therapies for, including ischemic stroke and acute respiratory distress syndrome (ARDS).

Read More

Transforming Antibody Detection
Industry Insight

Technology Networks recently spoke with Bryan Witherbee, CEO, Ardaza, to learn more about ZIVA, a multiplex label-free biosensor platform, and discuss some of the applications it could benefit.

Read More

Exploring the Use of Plasma Viscosity Testing in Diagnosing COVID-19 Severity
Industry Insight

To learn more about plasma viscosity and how it can be measured, as well as understand how this information could potentially be used to help diagnose and treat COVID-19 patients, Technology Networks spoke with Bernie Benson, MD of Benson Viscometers.

Read More

CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines
Industry Insight

This article provides tips and tricks for efficient delivery of CRISPR genome editing technology into primary cells and cell lines.

Read More

"Technology Dance" Looks Set To Transform the Field of DNA Synthesis
Industry Insight

Codexis and Molecular Assemblies recently announced a partnership through which the companies aim to engineer enzymes that will optimize the process of enzymatic DNA synthesis – an alternative approach to chemical DNA synthesis. Technology Networks spoke with Codexis to find out how this will transform the field of DNA synthesis.

Read More

Decoding the Immune System
Industry Insight

Our immune system is incredibly complex. Developing a complete understanding is an enormous undertaking but one to which scientists have been striving in order to advance disease understanding and improve treatments.

Read More

 
Advertisement